Supriya Lifescience Limited
SUPRIYA
Rank in Stocks
#11451
Supriya Lifescience Limited engages in the research and development,... Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in antihistamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, the company offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, it is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessation, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic stem cell transplantation, and anti-migraine. Supriya Lifescience Limited was founded in 1987 and is headquartered in Mumbai, India.
Share Price
$6.72
Last synced: 2026-11-13
Market Cap
$541.59M
Change (1 day)
-1.92%
Change (1 year)
-18.94%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Supriya Lifescience Limited (SUPRIYA)
Category
Healthcare
Operating Margin for Supriya Lifescience Limited (SUPRIYA)
Operating Margin as of November 2026 TTM: 33.78%
According to Supriya Lifescience Limited's latest financial reports, its current operating margin (TTM) is 33.78%. At the end of 2025 the company had an operating margin of 34.51%.
Operating Margin history for Supriya Lifescience Limited from 2018 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 33.78% | -2.12% |
| 2025 | 34.51% | 25.22% |
| 2024 | 27.56% | 7.78% |
| 2023 | 25.57% | -34.30% |
| 2022 | 38.92% | -8.79% |
| 2021 | 42.67% | 31.90% |
| 2020 | 32.35% | 47.11% |
| 2019 | 21.99% | 180.48% |
| 2018 | 7.84% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 59.80% | -98.23% |
US
|
|
| 31.60% | -99.06% |
SE
|
|
| 30.13% | -99.11% |
FR
|
|
| 29.76% | -99.12% |
HK
|
|
| 31.11% | -99.08% |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Supriya Lifescience Limited's operating margin
What is Supriya Lifescience Limited's operating margin?
Supriya Lifescience Limited's operating margin is 33.78%, as of Nov 2026.
What was Supriya Lifescience Limited's operating margin in 2025?
In 2025, Supriya Lifescience Limited's operating margin was 34.51%, compared with 27.56% in 2024.
How has Supriya Lifescience Limited's operating margin changed since 2020?
From 2020 to 2025, Supriya Lifescience Limited's operating margin was highest in 2021 (42.67%) and lowest in 2023 (25.57%).
How does Supriya Lifescience Limited's operating margin compare with similar companies?
Supriya Lifescience Limited's operating margin (33.78%) is higher than that of 4 of the 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 59.80%.